You are here
- Home
- Therapy Areas
- Neuroscience
Canada - SPARK
- Disease
- schizophrenia
- Drug Name
- Seroquel
- Generic Name
- quetiapine
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Other
- Start Date
- Oct 31, 2002
- Study Name
- DC-990-0113
- Study Id
- DC-990-0113
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
